[DPHARMA] QoQ TTM Result on 30-Jun-2015 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Jun-2015 [#2]
Profit Trend
QoQ- -4.59%
YoY- 8.26%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 304,911 271,040 232,663 197,750 182,065 176,961 171,671 46.61%
PBT 47,508 49,765 46,157 45,813 47,513 46,490 41,729 9.02%
Tax -9,864 -10,980 -8,786 -8,393 -8,428 -8,009 -7,856 16.36%
NP 37,644 38,785 37,371 37,420 39,085 38,481 33,873 7.28%
-
NP to SH 37,659 38,785 34,569 34,618 36,283 35,679 33,873 7.31%
-
Tax Rate 20.76% 22.06% 19.04% 18.32% 17.74% 17.23% 18.83% -
Total Cost 267,267 232,255 195,292 160,330 142,980 138,480 137,798 55.46%
-
Net Worth 457,740 270,323 268,530 189,815 205,045 192,951 187,531 81.18%
Dividend
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Div 5,682 5,682 25,710 25,710 25,682 25,682 24,291 -62.00%
Div Payout % 15.09% 14.65% 74.38% 74.27% 70.79% 71.98% 71.71% -
Equity
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Net Worth 457,740 270,323 268,530 189,815 205,045 192,951 187,531 81.18%
NOSH 278,959 278,959 278,959 139,570 139,486 138,813 138,912 59.10%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 12.35% 14.31% 16.06% 18.92% 21.47% 21.75% 19.73% -
ROE 8.23% 14.35% 12.87% 18.24% 17.70% 18.49% 18.06% -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 109.24 162.43 139.50 141.68 130.52 127.48 123.58 -7.88%
EPS 13.49 23.24 20.73 24.80 26.01 25.70 24.38 -32.57%
DPS 2.04 3.41 15.42 18.50 18.50 18.50 17.50 -76.10%
NAPS 1.64 1.62 1.61 1.36 1.47 1.39 1.35 13.83%
Adjusted Per Share Value based on latest NOSH - 139,570
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 31.70 28.18 24.19 20.56 18.93 18.40 17.85 46.59%
EPS 3.91 4.03 3.59 3.60 3.77 3.71 3.52 7.24%
DPS 0.59 0.59 2.67 2.67 2.67 2.67 2.53 -62.07%
NAPS 0.4759 0.281 0.2792 0.1973 0.2132 0.2006 0.195 81.16%
Price Multiplier on Financial Quarter End Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 -
Price 2.55 2.62 2.72 2.65 3.88 2.50 3.17 -
P/RPS 2.33 1.61 1.95 1.87 2.97 1.96 2.57 -6.32%
P/EPS 18.90 11.27 13.12 10.68 14.92 9.73 13.00 28.30%
EY 5.29 8.87 7.62 9.36 6.70 10.28 7.69 -22.05%
DY 0.80 1.30 5.67 6.98 4.77 7.40 5.52 -72.37%
P/NAPS 1.55 1.62 1.69 1.95 2.64 1.80 2.35 -24.20%
Price Multiplier on Announcement Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 18/05/16 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 21/11/14 -
Price 2.40 2.61 2.70 2.40 3.90 2.92 3.01 -
P/RPS 2.20 1.61 1.94 1.69 2.99 2.29 2.44 -6.66%
P/EPS 17.79 11.23 13.03 9.68 14.99 11.36 12.34 27.58%
EY 5.62 8.91 7.68 10.33 6.67 8.80 8.10 -21.60%
DY 0.85 1.30 5.71 7.71 4.74 6.34 5.81 -72.20%
P/NAPS 1.46 1.61 1.68 1.76 2.65 2.10 2.23 -24.58%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment